INTERCURE LTD. Inactive Instrument
InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
INCR
IL0011063760
Healthcare Facilities & Services
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 388.68 1.45K 32.46K | Sales 2023 | 355.55 1.32K 29.69K | Capitalization | 211M 785M 17.62B |
|---|---|---|---|---|---|
| Net income 2022 | 44M 164M 3.67B | Net income 2023 | -62M -231M -5.18B | EV / Sales 2022 | 14,73,908 x |
| Net Debt 2022 | 22.37M 83.17M 1.87B | Net Debt 2023 | 94.35M 351M 7.88B | EV / Sales 2023 | 8,58,938 x |
| P/E ratio 2022 |
12.2
x | P/E ratio 2023 |
-3.41
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.2% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 01/18/01 | |
Amos Cohen
DFI | Director of Finance/CFO | 45 | 01/20/01 |
Yisrael Gewirtz
AUD | Comptroller/Controller/Auditor | 47 | 01/14/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ehud Barak
CHM | Chairman | 81 | 01/18/01 |
| Chief Executive Officer | 53 | 01/18/01 | |
| Director/Board Member | 62 | 01/20/01 |
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 339M | |
| +34.02% | 277M | |
| +33.33% | 261M | |
| +39.53% | 182M | |
| -33.33% | 137M | |
| +50.41% | 136M | |
| -28.57% | 121M | |
| -7.69% | 80.3M | |
| +100.00% | 60.26M |
